Zevra Therapeutics
ZVRA
ZVRA
165 hedge funds and large institutions have $379M invested in Zevra Therapeutics in 2025 Q3 according to their latest regulatory filings, with 55 funds opening new positions, 52 increasing their positions, 37 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
19% more capital invested
Capital invested by funds: $319M → $379M (+$60.6M)
4.89% more ownership
Funds ownership: 66.19% → 71.08% (+4.9%)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
165
Holding in Top 10
4
Calls
$24.8M
Puts
$12.8M
Top Buyers
| 1 | +$10.5M | |
| 2 | +$9.15M | |
| 3 | +$6.93M | |
| 4 |
D.E. Shaw & Co
New York
|
+$5.38M |
| 5 |
CM
Caption Management
Oklahoma City,
Oklahoma
|
+$5.12M |
Top Sellers
| 1 | -$19.5M | |
| 2 | -$17.3M | |
| 3 | -$11.4M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.57M |
| 5 |
VCIM
Velan Capital Investment Management
Alpharetta,
Georgia
|
-$6.3M |
